Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,004.07
-3.9437-0.20%
Number of Gainers:300
Number of Losers:704
Number of Flat:17
PE:- -
High:2,022.71
Open:2,008.16
Low:2,003.79
Close:2,008.01
Volume:6.07B
Turnover:750.75B
Market Cap:95.78T
Float Cap:89.67T

Loading ...

GE Vernova Inc. (GEV) Receives a Buy from Jefferies

TIPRANKS
·
Sep 22

Dollar General (DG) Receives a Buy from Bernstein

TIPRANKS
·
Sep 22

Bernstein Sticks to Their Buy Rating for Costco (COST)

TIPRANKS
·
Sep 22

Bernstein Remains a Buy on Walmart (WMT)

TIPRANKS
·
Sep 22

Strategy price target raised to $195 from $175 at B. Riley

TIPRANKS
·
Sep 22

Carrier Global (CARR) Gets a Buy from UBS

TIPRANKS
·
Sep 22

AIM ImmunoTech Targets Q1 2027 Topline Data for Phase 2 Duripanc Trial of Ampligen Plus AstraZeneca’s Imfinzi in Pancreatic Cancer

Reuters
·
Sep 22

AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

GlobeNewswire
·
Sep 22

ChargePoint Price Target Raised to $9.00/Share from $8.00 by UBS

Dow Jones
·
Sep 22

Pre-Market: Nasdaq Futures Dip 0.02% as Brent Crude Falls Below $100

Deep News
·
Sep 22

'It Doesn't Seem Fair': I'm Retired and Have Plenty of Money. Why Can't I Qualify for a Retail Credit Card?

Dow Jones
·
Sep 22

Forge Nano and Nanexa to Develop Gmp-Compatible Ald Manufacturing Equipment

Reuters
·
Sep 22

Global Forex and Fixed Income Roundup: Market Talk

Dow Jones
·
Sep 22

Beyond Trade Figures: How Well Do We Really Know Our ASEAN Neighbor?

Deep News
·
Sep 22

AutoZone Says It’s Winning Market Share

Benzinga Earnings
·
Sep 22

Oppenheimer Adjusts Price Target on Microsoft to $570 From $515, Keeps Outperform Rating

MT Newswires Live
·
Sep 22

Vertex Pharmaceuticals Reports Positive Results for Inaxaplin Kidney Disease Trial

MT Newswires Live
·
Sep 22

US Stocks-S&P 500, Dow Set for Higher Open with Focus on Mideast Developments

Reuters
·
Sep 22

Maia Biotech Says Phase 3 THIO-104 Trial in Third-Line NSCLC Enrolls 65 Patients

Reuters
·
Sep 22

MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 22